Henan IVD Biotechnology Co., Ltd
Sorrento Therapeutics (NASDAQ:SRNE) is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments) and autoimmune diseases. Sorrento is also developing potential antiviral therapies and vaccines against Covid-19. Sorrento partners with Henan IVD Biotechnology commercializing diagnostic products including COVISTIX™ and COVIMARK™ both at home Covid-19 tests, along with tests for pregnancy, drug screening, and infectious diseases.
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!
YesIncluded in the Export Interest Directory?
YesProducts to be exported:
Covid-19 IVD productBusiness Needs:
Direct Sales, Distributor/Agent/Representative